BAT Lifts Annual Profit Growth Target As Velo Drives US Momentum
British American Tobacco (BAT) raised its full-year adjusted EPS growth outlook to the middle of its 5% to 8% medium-term range, up from earlier guidance at the low end, citing strong US momentum and demand for its Velo nicotine pouches, offsetting weaker Asia. It kept revenue and adjusted operating profit growth at the low end of 3% to 5% and 4% to 6%. Six-month adjusted EPS was 164p, up 7.9% vs a 158.5p consensus.
How this was made

The 30-second read
Why it matters
The company increased its full-year adjusted EPS growth expectation toward the middle of its medium-term range, attributing improvement to Velo demand and US momentum while acknowledging Asia weakness and an AI-driven restructuring.
Market read
A guidance step-up tied to modern oral momentum can drive re-rating, but the stock’s early weakness signals investors are still weighing restructuring and regional demand risks.
What to watch
The article does not quantify restructuring cost impact or the sustainability of Velo growth; traders may need to watch margin and volume share trends beyond the stated category growth.
Background
BAT is transitioning profits away from traditional cigarettes via investments in smoking alternatives, including nicotine pouches (Velo) and modern oral categories.
Ticker impact
BAT raised its full-year adjusted EPS growth outlook toward the mid of its 5% to 8% range, citing Velo strength and US momentum.
Near-term bias higher as investors re-rate the earnings trajectory; follow-through depends on whether Velo and US trends persist despite Asia weakness.
The article is a fresh guidance update with specific directional change and supporting operating drivers (Velo, US), plus explicit headwinds (Asia decline, restructuring, AI-driven job cuts).
Market effects
Reinforces the shift from combustible cigarettes to modern oral and vapes, highlighting nicotine pouch momentum as a driver of earnings expectations.
US outperformance is explicitly offsetting Asia demand declines, suggesting regional divergence in tobacco demand trends.
Could influence how investors model peers’ modern oral growth and restructuring execution risk across major markets.
Counterpoint
The guidance lift may be more about mix and timing than durable demand, especially with Asia still sharply weaker and restructuring excluding the US.
Key entities
- companyBritish American Tobacco
Raised full-year adjusted EPS growth outlook, citing Velo nicotine pouch demand and strong US performance, while noting Asia decline and restructuring.
- product_categoryVelo
Nicotine pouch brand whose surging demand is cited as a key driver of US momentum and earnings outlook.
- third_partyAccenture
Named as a beneficiary of shifted roles to third parties in BAT’s restructuring plan.
- regulatorUS FDA
Cited as enabling sales of some unlicensed vapes, potentially expanding the US market for BAT’s alternatives.
